Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 210.98M P/E - EPS this Y -12.40% Ern Qtrly Grth -
Income -36.4M Forward P/E -5.56 EPS next Y 10.20% 50D Avg Chg -17.00%
Sales 50.23M PEG - EPS past 5Y - 200D Avg Chg -28.00%
Dividend N/A Price/Book 1.16 EPS next 5Y - 52W High Chg -75.00%
Recommedations 1.20 Quick Ratio 6.86 Shares Outstanding 32.91M 52W Low Chg 15.00%
Insider Own 7.66% ROA -12.00% Shares Float 24.63M Beta 0.93
Inst Own 85.55% ROE -20.44% Shares Shorted/Prior 1.15M/1.07M Price 6.56
Gross Margin 50.41% Profit Margin -72.47% Avg. Volume 231,262 Target Price 15.33
Oper. Margin -70.02% Earnings Date May 7 Volume 107,307 Change -0.91%
About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908 Devices Inc. News
03/12/24 908 Devices Trace Chemical Identification Technology Adopted by European Agencies
03/07/24 908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call Transcript
03/05/24 908 Devices Inc (MASS) Reports Growth Amidst Industry Headwinds
03/05/24 908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
02/29/24 908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
02/22/24 908 Devices to Participate in Upcoming Investor Conferences
02/20/24 908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
02/09/24 We're Not Very Worried About 908 Devices' (NASDAQ:MASS) Cash Burn Rate
02/02/24 908 Devices Inc CFO Griffith Joseph H. IV Sells 15,409 Shares
12/28/23 908 Devices Inc. (MASS) Upgraded to Buy: What Does It Mean for the Stock?
12/28/23 Trending tickers: Bitcoin | Oil | Tesla | Apple
12/27/23 2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
12/22/23 Chief Product Officer Christopher Brown Sells 20,000 Shares of 908 Devices Inc
09:55 AM How Much Upside is Left in 908 Devices Inc. (MASS)? Wall Street Analysts Think 100.39%
12/18/23 3 Russell 2000 Stocks That Are About to Get Absolutely Crushed
11/14/23 908 Devices Announces MX908 Integration Capabilities
11/09/23 908 Devices Inc. (NASDAQ:MASS) Q3 2023 Earnings Call Transcript
11/07/23 908 Devices Inc (MASS) Reports 9% Decrease in Q3 2023 Revenue, Narrows Full-Year Outlook
11/07/23 908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook
11/06/23 908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
MASS Chatroom

User Image Deadman3906 Posted - 2 weeks ago

$DJT $BAT.X $MASS $TER $SON joined the Navy

User Image DonCorleone77 Posted - 1 month ago

$MASS 908 Devices trace chemical identification technology chosen by European agencies 908 Devices announced the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats. DrugDetect EU and NATO Support and Procurement Agency, or NSPA, have both entered into new contracts to deploy the MX908, a handheld high-pressure mass spectrometry, or HPMS, device. The MX908 will be used in a variety of settings, from military applications to correctional facilities.

User Image Stock_Titan Posted - 1 month ago

$MASS 908 Devices Trace Chemical Identification Technology Adopted by European Agencies https://www.stocktitan.net/news/MASS/908-devices-trace-chemical-identification-technology-adopted-by-l48wv90v163i.html

User Image JasonLg Posted - 1 month ago

$MASS H&S

User Image DonCorleone77 Posted - 1 month ago

$MASS 908 Devices sees FY24 revenue $52M-$54M, consensus $55.51M The company said, "908 Devices expects full year 2024 revenue to be in the range of $52.0 million to $54.0 million, representing 4% to 8% growth over full year 2023."

User Image DonCorleone77 Posted - 1 month ago

$MASS 908 Devices reports Q4 EPS (23c), consensus (26c) Reports Q4 revenue $14.35M, consensus $14.16M. "We made solid progress in 2023 towards our objectives. We have continued to see sustained growth of our handheld devices servicing customers in their efforts to combat the ongoing crisis of counterfeit drugs and opioids. For the full year we saw 28% growth in our handheld revenue and consistent year-over-year growth each quarter. Despite near-term headwinds impacting the life science instrumentation and bioprocessing industries, we launched two additional desktop devices in the Process Analytical Technology (PAT) space, positioning us for accelerated growth as conditions improve," said Kevin Knopp, CEO and co-founder. "We remain focused on expanding our market presence, extending our global reach, leveraging our expanded product portfolios, and overall efficient execution and cash management as we march towards scale and profitability."

User Image epsguid Posted - 1 month ago

$MASS reported a loss of $0.23, consensus was ($0.27) via @eWhispers #epsbeat http://eps.sh/d/mass

User Image Stock_Titan Posted - 1 month ago

$MASS 908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook https://www.stocktitan.net/news/MASS/908-devices-reports-fourth-quarter-and-full-year-2023-financial-86jzryllubju.html

User Image jimmyhunt Posted - 02/29/24

$MASS 12% so far

User Image Stock_Titan Posted - 02/29/24

$MASS 908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform https://www.stocktitan.net/news/MASS/908-devices-and-cellares-collaborate-to-integrate-in-line-monitoring-eaa3b3xp7ka6.html

User Image jimmyhunt Posted - 02/27/24

$MASS Cathie loading this one, hmmmm

User Image Stock_Titan Posted - 02/22/24

$MASS 908 Devices to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/MASS/908-devices-to-participate-in-upcoming-investor-8qwfcf17rybs.html

User Image Stock_Titan Posted - 02/20/24

$MASS 908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 https://www.stocktitan.net/news/MASS/908-devices-to-report-fourth-quarter-and-full-year-2023-financial-21fzpg16ogu1.html

User Image insiderbuyingselling Posted - 2 months ago

$MASS new insider selling: 15409 shares. http://insiderbuyingselling.com/?t=MASS

User Image insiderbuyingselling Posted - 2 months ago

$MASS new insider selling: 9071 shares. http://insiderbuyingselling.com/?t=MASS

User Image TrendyChart Posted - 01/23/24

$MASS Technical patterns on the stock chart paint a picture of potential prosperity, with support levels bolstering its foundation and ensuring stability, creating a pathway to success. 🏰

User Image StockAutomatePro Posted - 01/23/24

$MASS The stock looks poised for growth based on the chart. We alerted the BUY signal at $7.69 and we were able to close this one with profit at $8.27 🎲

User Image LaurieHurley Posted - 01/23/24

$MASS ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Dec Watch out for our next alert;;;;',,,💖👉 top-stocks-great-winning-trades-chat.profitablestocks.vip/

User Image Allin508 Posted - 01/22/24

$MASS $MCAF 🔜👿👿👿👿🤨🤨🤨🤨🤨

User Image UltraAlgo Posted - 01/22/24

$MASS 10.24% down since our sell rating. See the AI powered signals in real-time at UltraAlgo.com

User Image StockAutomatePro Posted - 3 months ago

$MASS Looks like the stock is in for a rough stretch according to the chart. We alerted the SELL signal at $11.8 and we were able to close this one with profit at $8.58🤙 See more details at StockAutomate.com

User Image PulsarTrades Posted - 3 months ago

Disappointing follow through $MASS

User Image InsiderPeek Posted - 3 months ago

$MASS CFO Griffith Joseph H. IV sold 6k shares for $72.5k (ownership down 6.98%) insiderpeek.com/company/MASS

User Image cctranscripts Posted - 3 months ago

MassRoots, Inc. insider just disposed of 6,000 shares https://www.conferencecalltranscripts.org/summary/?id=12835314 $MASS

User Image risenhoover Posted - 3 months ago

Insider Griffith Joseph H. IV reports selling 6,000 shares of $MASS for a total cost of $72,480.00 https://fintel.io/n/us/mass/griffith-joseph-h-iv?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image turnNburner Posted - 3 months ago

$MASS what happened over NYE to mass??? no news anywhere...

User Image tickeron Posted - 3 months ago

A.I.dvisor made a bullish call on $MASS, netting in a 21.96% gain over 4 days https://srnk.us/go/4958202

User Image lordBrian Posted - 3 months ago

$MASS 13 dollar stock. Easy

User Image tickeron Posted - 12/31/23

A.I.dvisor made a bullish call on $MASS, netting in a 33.58% gain over 1 month https://srnk.us/go/4956277

User Image tickeron Posted - 12/31/23

A.I.dvisor made a bullish call on $MASS, netting in a 31.63% gain over 1 month https://srnk.us/go/4956249

Analyst Ratings
Stephens & Co. Overweight Sep 25, 23
Stephens & Co. Overweight Feb 7, 23
SVB Leerink Outperform Jan 6, 23
SVB Leerink Outperform Nov 15, 22
SVB Leerink Outperform Mar 8, 22
SVB Leerink Outperform May 14, 21
Stifel Buy Jan 12, 21
Cowen & Co. Outperform Jan 12, 21
SVB Leerink Outperform Jan 12, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 7.03 15,409 108,325 80,000 02/02/24
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Dec 28 Sell 12.08 6,000 72,480 80,000 01/02/24
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Dec 19 Sell 9.08 5,580 50,666 86,000 12/21/23
Brown Christopher D. Chief Product Office.. Chief Product Officer Dec 19 Sell 9.1 20,000 182,000 877,905 12/21/23
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Mar 22 Option 1.58 5,000 7,900 96,580 03/23/23
Turner Michael S. VP, General Counsel VP, General Counsel Feb 01 Sell 9.6 4,427 42,499 02/03/23
Knopp Kevin J. President and CEO President and CEO Feb 01 Sell 9.94 44,049 437,847 447,848 02/03/23
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 9.6 5,102 48,979 91,580 02/03/23
Fitzpatrick Maura VP, Product Manageme.. VP, Product Management & Mktg Feb 01 Sell 9.2 1,593 14,656 2,834 02/03/23
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Feb 01 Sell 9.6 11,564 111,014 902,375 02/03/23
Turner Michael S. VP, General Counsel VP, General Counsel Aug 17 Option 7.91 5,000 39,550 5,000 08/18/22
Turner Michael S. VP, General Counsel VP, General Counsel Aug 17 Sell 18.15 5,000 90,750 08/18/22
Knopp Kevin J. President and CEO President and CEO Aug 15 Sell 19.48 30,000 584,400 560,642 08/17/22
Knopp Kevin J. President and CEO President and CEO Aug 05 Sell 25.25 26,196 661,449 590,642 08/09/22
Knopp Kevin J. President and CEO President and CEO Jul 28 Sell 22.23 38,347 852,454 616,838 08/01/22
Knopp Kevin J. President and CEO President and CEO Jul 21 Sell 22.04 200 4,408 655,185 07/25/22
Knopp Kevin J. President and CEO President and CEO Jul 15 Sell 17.27 30,000 518,100 655,385 07/19/22
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Jul 06 Sell 21.41 10,000 214,100 928,912 07/08/22
Knopp Kevin J. President and CEO President and CEO Jul 06 Sell 22.07 1,453 32,068 685,385 07/08/22
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Jun 24 Option 0.96 18,188 17,460 96,639 06/27/22
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Jun 24 Sell 19.11 18,188 347,573 91,580 06/27/22
Turner Michael S. VP, General Counsel VP, General Counsel Jun 23 Option 7.91 10,000 79,100 15,000 06/27/22
Turner Michael S. VP, General Counsel VP, General Counsel Jun 23 Sell 17.9 10,000 179,000 5,000 06/27/22
Kenneweg John Vice President, Gove.. Vice President, Government Apr 12 Option 0.35 9,880 3,458 9,880 04/14/22
Kenneweg John Vice President, Gove.. Vice President, Government Apr 12 Sell 20.07 9,880 198,292 04/14/22
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Apr 12 Sell 20.06 9,829 197,170 959,083 04/14/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Apr 11 Option 1.75 30,000 52,500 90,000 04/13/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Apr 11 Sell 19.96 15,000 299,400 75,000 04/13/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 18 Option 0.35 19,881 6,958 19,881 03/21/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 18 Sell 20.06 19,881 398,813 03/21/22
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Mar 11 Sell 20.00 100 2,000 988,812 03/15/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 11 Sell 20 119 2,380 03/15/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 11 Option 0.35 119 42 119 03/15/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Mar 14 Option 2.5 15,000 37,500 75,000 03/15/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Mar 14 Sell 17.71 15,000 265,650 60,000 03/15/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Feb 14 Option 1.75 15,000 26,250 54,292 02/16/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Feb 14 Sell 15.17 15,000 227,550 45,000 02/16/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Jan 12 Option 1.75 15,000 26,250 60,000 01/14/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Jan 12 Sell 19.81 15,000 297,150 45,000 01/14/22
Kenneweg John Vice President, Gove.. Vice President, Government Jan 10 Option 0.35 10,000 3,500 9,300 01/12/22
Kenneweg John Vice President, Gove.. Vice President, Government Jan 10 Sell 20.1 10,000 201,000 01/12/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Aug 25 Sell 34.42 36,997 1,273,437 35,000 08/25/21
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Aug 25 Option 1.75 36,997 64,745 36,600 08/25/21